PepGen (PEPG) Stock Price, News & Analysis

-0.49 (-3.59%)
(As of 05/17/2024 08:54 PM ET)
Today's Range
50-Day Range
52-Week Range
41,300 shs
Average Volume
105,148 shs
Market Capitalization
$426.65 million
P/E Ratio
Dividend Yield
Price Target

PepGen MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
87.4% Upside
$24.67 Price Target
Short Interest
1.66% of Float Sold Short
Dividend Strength
News Sentiment
0.42mentions of PepGen in the last 14 days
Based on 35 Articles This Week
Insider Trading
Selling Shares
$134,100 Sold Last Quarter
Proj. Earnings Growth
From ($2.96) to ($2.81) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.89 out of 5 stars

Medical Sector

594th out of 914 stocks

Pharmaceutical Preparations Industry

278th out of 427 stocks

PEPG stock logo

About PepGen Stock (NASDAQ:PEPG)

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts.

PEPG Stock Price History

PEPG Stock News Headlines

PepGen's (PEPG) "Buy" Rating Reaffirmed at HC Wainwright
PepGen (NASDAQ:PEPG) Earns Outperform Rating from Wedbush
PepGen to Participate in Upcoming Investor Conferences
Stifel Nicolaus Reaffirms Their Buy Rating on PepGen Inc. (PEPG)
PEPG Stock Earnings: PepGen Beats EPS for Q4 2023
See More Headlines
Receive PEPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PepGen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Pharmaceutical preparations
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
2 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
Book Value
$5.52 per share


Free Float
Market Cap
$426.65 million
Not Optionable
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Dr. James G. McArthur Ph.D. (Age 62)
    President, CEO, Treasurer, Secretary & Director
    Comp: $834.98k
  • Mr. Noel P. Donnelly M.B.A. (Age 54)
    Chief Financial Officer
    Comp: $650.17k
  • Mr. Niels Svenstrup Ph.D. (Age 54)
    Senior Vice President of Chemistry, Manufacturing & Control
    Comp: $455.15k
  • Dr. Michael Gait Ph.D.
    Founder & Scientific Advisory Board Member
  • Ms. Emiko Bryant
    Chief of Staff
  • Mr. Kyle Breidenstine
    VP of Finance & Controller

PEPG Stock Analysis - Frequently Asked Questions

Should I buy or sell PepGen stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PepGen in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PEPG shares.
View PEPG analyst ratings
or view top-rated stocks.

What is PepGen's stock price target for 2024?

2 Wall Street research analysts have issued twelve-month target prices for PepGen's stock. Their PEPG share price targets range from $20.00 to $28.00. On average, they predict the company's stock price to reach $24.67 in the next year. This suggests a possible upside of 87.4% from the stock's current price.
View analysts price targets for PEPG
or view top-rated stocks among Wall Street analysts.

How have PEPG shares performed in 2024?

PepGen's stock was trading at $6.80 on January 1st, 2024. Since then, PEPG stock has increased by 93.5% and is now trading at $13.16.
View the best growth stocks for 2024 here

When is PepGen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024.
View our PEPG earnings forecast

How were PepGen's earnings last quarter?

PepGen Inc. (NASDAQ:PEPG) released its earnings results on Wednesday, March, 6th. The company reported ($0.82) EPS for the quarter, beating the consensus estimate of ($1.01) by $0.19.

What ETFs hold PepGen's stock?

ETFs with the largest weight of PepGen (NASDAQ:PEPG) stock in their portfolio include Morningstar US Small Growth (MSGR).iShares Neuroscience and Healthcare ETF (IBRN).

When did PepGen IPO?

PepGen (PEPG) raised $126 million in an initial public offering (IPO) on Friday, May 6th 2022. The company issued 9,000,000 shares at a price of $13.00-$15.00 per share.

Who are PepGen's major shareholders?

PepGen's stock is owned by many different retail and institutional investors. Top institutional investors include RA Capital Management L.P. (32.97%), Janus Henderson Group PLC (3.60%), Vanguard Group Inc. (2.63%), Artal Group S.A. (0.62%) and Acadian Asset Management LLC (0.01%). Insiders that own company stock include James G Mcarthur, Jaya Goyal, Niels Svenstrup and Ra Capital Management, LP.
View institutional ownership trends

How do I buy shares of PepGen?

Shares of PEPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PEPG) was last updated on 5/20/2024 by Staff

From Our Partners